06 Jun 2022
Professor Constantin Coussios honoured in 2022 Queen’s Birthday Honours List
Professor Constantin Coussios FREng is appointed OBE for his services to Biomedical Engineering
A Fellow of Magdalen College, Professor Coussios was elected in 2011 as the University of Oxford’s first Statutory Chair in Biomedical Engineering, and has served as Director of the Institute of Biomedical Engineering (IBME) since 2016.
Professor Coussios founded and heads the Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory (BUBBL) and serves as the Founding Director of the new Podium Analytics Institute for Youth Sports Medicine and Technology at Oxford.
In 2008, working with Professor of Transplantation Peter Friend, he co-founded OrganOx Ltd., and led the engineering development of the world’s first normothermic liver perfusion device for improved organ preservation prior to transplantation, now in clinical adoption in Europe and North America. He subsequently led the engineering development of the first normothermic kidney device capable of 24-hour perfusion, currently in clinical trials in Oxford.
In 2014, he was the lead academic founder of OxSonics Ltd., which exploits ultrasound and bubbles to enhance drug delivery to tumours, a technique which has recently entered clinical trials to treat patients with metastatic colorectal cancer. In 2016, Professor Coussios co-founded OrthoSon Ltd., which is developing a new minimally invasive technique to treat lower back pain.
Professor Coussios says: "No honour has ever surprised me more. I am extremely grateful to my amazing students and academic colleagues within the University, to my fantastic co-workers within OrganOx, OxSonics and OrthoSon, and to the extraordinary Oxford biomedical innovation ecosystem for enabling the generation and successful translation of new engineering and cross-disciplinary technologies from bench to bedside."
Head of Department Professor Ronald A. Roy says, "Professor Coussios has been an exceptional contributor to the research and teaching missions of the department. His groundbreaking work on therapeutic ultrasonics and drug delivery is central to the expanding IBME research portfolio. The department is fortunate to have him as a member of Faculty and we are very pleased to see him receive this great honour from the Queen."